{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:50:58Z","timestamp":1786636258861,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J App Basic Med Res"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4103\/2229-516x.81977","type":"journal-article","created":{"date-parts":[[2011,6,9]],"date-time":"2011-06-09T13:21:54Z","timestamp":1307625714000},"page":"31","source":"Crossref","is-referenced-by-count":21,"title":["Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim"],"prefix":"10.4103","volume":"1","author":[{"given":"Ranabir","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingmaL","family":"Sherpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazum","family":"Bhutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-516X.81977-1","first-page":"1108","volume-title":"The 1997 American Diabetic association and 1999 WHO criteria for hyperglycemia in diagnosis and prediction of diabetes","author":"Gabir","year":"2000","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2229-516X.81977-2","first-page":"518","volume-title":"Prevalence of diabetes impaired fasting glucose and impaired glucose tolerance test","author":"Harris","year":"1998","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2229-516X.81977-3","unstructured":"Lawrence M, Tierney Jr, McPhee SJ, Papadakis MA. Current Medical diagnosis and treatment. New York: McGraw-Hill Medical; London: McGraw-Hill; 2006. p. 41."},{"key":"key-10.4103\/2229-516X.81977-4","unstructured":"WHO 1998-Prevention and control of Diabetes Mellitus, Report of an Intercountry workshop, Dhaka, Bangladesh: 1998, SEA\/NCD\/40."},{"key":"key-10.4103\/2229-516X.81977-5","first-page":"223","volume-title":"Advanced protein glycosylation in diabetes and aging","author":"Brownlee","year":"1995","journal-title":"Annu Rev Med"},{"key":"key-10.4103\/2229-516X.81977-6","first-page":"2146","volume-title":"Nitric oxide synthases: Which, where, how and why?","author":"Michel","year":"1997","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2229-516X.81977-7","first-page":"976","volume-title":"Vasorelaxation by red blood cells and impairment in diabetes","author":"James","year":"2004","journal-title":"Circ Res"},{"key":"key-10.4103\/2229-516X.81977-8","first-page":"S35","volume-title":"Insulin resistance: Potential role of the endogenous nitric oxide synthase inhibitor ADMA","author":"Sydow","year":"2005","journal-title":"Vasc Med"},{"key":"key-10.4103\/2229-516X.81977-9","first-page":"655","volume-title":"Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance","author":"Toutouzas","year":"2008","journal-title":"Horm Metab Res"},{"key":"key-10.4103\/2229-516X.81977-10","first-page":"973","volume-title":"Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes","author":"Yamagishi","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/2229-516X.81977-11","first-page":"1049","volume-title":"Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","author":"Du","year":"2003","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2229-516X.81977-12","unstructured":"WHO study group. Diabetes Mellitus Technical Report Series 727. Geneva: World health Organization; 1985."},{"key":"key-10.4103\/2229-516X.81977-13","first-page":"24","volume-title":"Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor","author":"Trinder","year":"1969","journal-title":"Ann Clin Biochem"},{"key":"key-10.4103\/2229-516X.81977-14","first-page":"470","volume-title":"CHOD-PAP method for determination of total cholesterol","author":"Allian","year":"1974","journal-title":"Clin Chem"},{"key":"key-10.4103\/2229-516X.81977-15","first-page":"476","volume-title":"Quantitative determination of serum triglycerides by the use of enzymes","author":"Bucolo","year":"1973","journal-title":"Clin Chem"},{"key":"key-10.4103\/2229-516X.81977-16","first-page":"371","volume-title":"Improved method for determination of high density lipoprotein cholesterol, I: Isolation of high density lipoprotein by use of polyethylene glycol 6000","author":"Izzo","year":"1981","journal-title":"Clin Chem"},{"key":"key-10.4103\/2229-516X.81977-17","first-page":"15","volume-title":"Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints","author":"Warnick","year":"1990","journal-title":"Clin Chem"},{"key":"key-10.4103\/2229-516X.81977-18","first-page":"499","volume-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"key-10.4103\/2229-516X.81977-19","first-page":"237","volume-title":"Quantitation of nitrite and nitrate in extra-cellular fluids","author":"Mathew","year":"1996","journal-title":"Met Enzymol"},{"key":"key-10.4103\/2229-516X.81977-20","first-page":"393","volume-title":"Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy","author":"Ozden","year":"2003","journal-title":"Can J Ophthalmol"},{"key":"key-10.4103\/2229-516X.81977-21","first-page":"343","volume-title":"Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: Relation to glomerular hyperfiltration","author":"Apakkan","year":"2003","journal-title":"J Diabetes Compl"},{"key":"key-10.4103\/2229-516X.81977-22","first-page":"465","volume-title":"Relation Between Plasma Nitric Oxide Levels and Diabetic Retinopathy","author":"Izumi","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/2229-516X.81977-23","unstructured":"Khan M A. Nitric Oxide and Lipid Peroxidation Status in Diabetes Mellitus and Hypertension. PhD thesis, University of Karachi, Karachi. ID Code: 1134."},{"key":"key-10.4103\/2229-516X.81977-24","first-page":"1342","volume-title":"Serum nitric oxide metabolites in subjects with metabolic syndrome","author":"Asl","year":"2008","journal-title":"Clin Biochem"},{"key":"key-10.4103\/2229-516X.81977-25","first-page":"80","volume-title":"Serum nitric oxide in patients with acute coronary syndromes: Correlation with the extent of myocardial ischemia and role of diabetes mellitus","author":"Rizk","year":"2004","journal-title":"Crit Care"},{"key":"key-10.4103\/2229-516X.81977-26","first-page":"1323","volume-title":"Correlation Between Glycosylated Hemoglobin (HbA1c) and Serum Nitric Oxide (NO)","author":"Shahid","year":"2009","journal-title":"Aust J Basic Appl Sci"},{"key":"key-10.4103\/2229-516X.81977-27","first-page":"342","volume-title":"Possible Involvement of Nitric Oxide in the Progression of Diabetic Retinopathy","author":"Tsai","year":"2003","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/2229-516X.81977-28","first-page":"2518","volume-title":"Endothelial function predicts future development of coronary artery disease: A study of women with chest pain and normal coronary angiograms","author":"Bugiardini","year":"2004","journal-title":"Circulation"},{"key":"key-10.4103\/2229-516X.81977-29","first-page":"653","volume-title":"Prognostic value of coronary vascular endothelial dysfunction","author":"Halcox","year":"2002","journal-title":"Circulation"},{"key":"key-10.4103\/2229-516X.81977-30","first-page":"2842","volume-title":"Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Explains the \"L-Arginine Paradox\" and Acts as a Novel Cardiovascular Risk Factor","author":"Boger","year":"2004","journal-title":"J Nutr"},{"key":"key-10.4103\/2229-516X.81977-31","first-page":"21","volume-title":"Comparison of the effects of simvastatin versus atorvastatin on oxidative stress in patients with type 2 diabetes mellitus","author":"Su","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"key-10.4103\/2229-516X.81977-32","first-page":"507","volume-title":"Insulin Action Is Associated With Endothelial Function in Hypertension and Type 2 Diabetes","author":"Cleland","year":"2000","journal-title":"Hypertension"},{"key":"key-10.4103\/2229-516X.81977-33","first-page":"41","volume-title":"Plasma total homocysteine concentrations in obese and non-obese female patients with type 2 diabetes mellitus; its relations with plasma oxidative stress and nitric oxide levels","author":"Konukoglu","year":"2005","journal-title":"Clin Hemorheol Microcirc"},{"key":"key-10.4103\/2229-516X.81977-34","first-page":"1120","volume-title":"L-arginine infusion decrease plasma total homocysteine concentration through increased nitric oxide production and decreased oxidative status in Type II diabetic patients","author":"Cassone-Faldetta","year":"2002","journal-title":"Diabetologia"},{"key":"key-10.4103\/2229-516X.81977-35","first-page":"161","volume-title":"Evaluation of some biochemical changes in diabetic patients","author":"Abou-Seif","year":"2004","journal-title":"Clin Chim Acta"},{"key":"key-10.4103\/2229-516X.81977-36","first-page":"343","volume-title":"Serum and urinary nitric oxide in type 2 diabetes with or without microalbuminuria: Relation to glomerular hyperfiltration","author":"Apakkan","year":"2003","journal-title":"J Diabetes Compl"},{"key":"key-10.4103\/2229-516X.81977-37","first-page":"123","volume-title":"The effect of glipizide, metformin and rosiglitazone on nontraditional cardiovascular risk factors in newly diagnosed patients with type 2 diabetes mellitus","author":"Gupta","year":"2010","journal-title":"Int J Diab Dev Ctries","ISSN":"https:\/\/id.crossref.org\/issn\/0973-3930","issn-type":"print"}],"container-title":["International Journal of Applied and Basic Medical Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:55:24Z","timestamp":1786632924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2229-516X.81977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"alternative-id":["81977"],"URL":"https:\/\/doi.org\/10.4103\/2229-516x.81977","relation":{},"ISSN":["2229-516X"],"issn-type":[{"value":"2229-516X","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}